Pharmacy research in the emergency medicine environment
2019; Wiley; Volume: 49; Issue: 2 Linguagem: Inglês
10.1002/jppr.1547
ISSN1445-937X
Autores Tópico(s)Pharmaceutical studies and practices
ResumoJournal of Pharmacy Practice and ResearchVolume 49, Issue 2 p. 104-106 EditorialsFree Access Pharmacy research in the emergency medicine environment Susan Welch BPharm, Cert Pharm Prac, Susan Welch BPharm, Cert Pharm Prac Chair, SHPA Emergency Medicine Specialty Practice Leadership Group; Senior Pharmacist Susan.Welch@svha.org.au St. Vincent's Hospital, Sydney, NSW, AustraliaSearch for more papers by this author Susan Welch BPharm, Cert Pharm Prac, Susan Welch BPharm, Cert Pharm Prac Chair, SHPA Emergency Medicine Specialty Practice Leadership Group; Senior Pharmacist Susan.Welch@svha.org.au St. Vincent's Hospital, Sydney, NSW, AustraliaSearch for more papers by this author First published: 16 April 2019 https://doi.org/10.1002/jppr.1547AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Australian emergency medicine (EM) pharmacy practice has come a long way since the 1990s. It has now reached the dizzy heights of providing opportunities for EM pharmacy research. This is evidenced by the increasing number of publications in our own Journal of Pharmacy Practice and Research, including this issue, and other EM-related journals such as Emergency Medicine Australasia, the flagship journal of the Australasian College for Emergency Medicine. In addition, there are an ever-increasing number of EM-related presentations at the annual Society of Hospital Pharmacists of Australia (SHPA) Medicines Management (MM) conferences: 16 EM-related abstracts were presented at MM2018 in Brisbane. It is no longer a rarity to have EM research completed and displayed in these settings: fantastic news! Why? The benefits of EM pharmacy research are twofold: (1) it provides support for the extension of pharmacy services within the emergency department (ED); and (2) it shows to us and others how pharmacists are involved in or are directing research in this area of practice. The impacts of pharmacist clinical activities in the ED have been explored in a variety of projects.1-5 Pharmacists are pushing the boundaries of service provision. As well as investigating the fundamentals, they are involved in research in various EM-specific clinical areas.6-11 As medication experts, pharmacists provide a unique medication focus in multidisciplinary collaborations. Many EM pharmacists are now leading or are involved with a range of multidisciplinary projects in the ED.12-16 Pharmacists are an integral part of the research team and are recognised for it. Being involved in multidisciplinary research then leads to greater pharmacist collaboration with all professions within the ED, at all levels. These contributions can result in improvements in medication and patient safety, clinical governance, education and training, as well as patient-centred care, to name but a few. Through the work of the SHPA Specialty Practice Group (formerly the ED Committee of Specialty Practice), multicentre EM pharmacy research has progressed. A number of studies have been conducted by its members, which have benefited many and provided much needed clinical and practical evidence used by EM pharmacists and their managers across the country.17 The most recent of these will build on previous work and help answer the age-old problem faced by EM pharmacists: how should EM pharmacists prioritise patients to be seen in the ED?18, 19 This has followed the model used by other professional groups to answer questions and enhance learning by harnessing peers at many hospital sites in different states for the greater good (e.g. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials group and, more recently, the model to be used by the SHPA National Translational Research Collaborative (NTRC) launched in 2017). Through this process, other specialty practice groups can benefit from the lessons learned and hurdles scaled to enable these projects to succeed. We endeavour to expand our collaboration to include international collaborations. This is the way forward and all those involved in the journey in the past, present and into the future should be congratulated…keep going. Conflict of interests statement The author declares that she has no conflicts of interest. References 1deClifford JM, Caplygin F, Lam S. Impact of an ED pharmacist on prescribing error in an Australian Hospital. J Pharm Pract Res 2007; 37: 284– 6. 2Vasileff HM, Whitten LE, Pink JA, Goldsworthy SJ, Angley MT. The effect on medication errors of pharmacists charting medication in an emergency department. Pharm World Sci 2009; 31: 373– 9. 3Lawrence DS, Masood N, Astles D, Fitzgerald CE, Bari AU. Impact of pharmacist-led medication reconciliation on admission using electronic medical records on accuracy of discharge prescriptions. J Pharm Pract Res 2015; 45: 166– 73. 4Briggs S, Pearce R, Dilworth S, Higgins I, Hullick C, Attia J. Clinical pharmacist review: a randomised controlled trial. Emerg Med Australas 2015; 27: 419– 26. 5Proper J, Wong A, Plath A, Grant K, Just D, Dulhunty J. Impact of clinical pharmacists in the emergency department of an Australian public hospital: a before and after study. Emerg Med Australas 2015; 27: 232– 8. 6Welch S, Samios P. Barcode technology and emergency medicine pharmacy. J Pharm Pract Res 2016; 47: 53– 6. 7Currey E, Sue N. Highlighting the need for emergency department resuscitation pharmacists [abstract]. Proceedings of Medicines Management. The 44th SHPA National Conference; 2018 Nov 22–25; Brisbane, Australia. 2018. p. 173– 4. 8Roman C, Dooley M, Mitra B. Early involvement of the emergency department pharmacist in severe trauma. Emerg Med Australas 2018; 30: 285. 9Welch S. Antimicrobial stewardship in Australian emergency departments. Emerg Med Australas 2015; 27: 427– 30. 10Wisdom A, Eaton V, Gordon D, Daniel S, Woodman R, Phillips C. Impact of timing of initiation of antibiotic therapy on mortality of patients presenting to an emergency department with sepsis. Emerg Med Australas 2015; 27: 196– 201. 11Tong EY, Roman C, Mitra B, Yip G, Gibbs H, Newnham H, et al. Partnered pharmacist charting on admission in the General Medical and Emergency Short-stay Unit – a cluster-randomised controlled trial in patients with complex medication regimens. J Clin Pharm Ther 2016; 41: 414– 18. 12Morrow M, Ward L, Patel B, Pache DM. Review of the use of medication standing orders in Australian emergency departments [abstract]. Proceedings of Medicines Management; The 43rd SHPA National Conference, 2017 Nov 16-19; Sydney, Australia. 2017. p. 91. 13Schwarz G, Harding A, Donaldson A, Greene S. Modifying emergency department electronic prescribing for outpatient opioid analgesia. Emerg Med Australas 2018. 1– 6. https://doi.org/10.1111/1742–6723.13192 14Graudins A, Meek R, Parkinson J, Egerton-Warburton D, Meyer A. A randomised controlled trial of paracetamol and ibuprofen with or without codeine or oxycodone as initial analgesia for adults with moderate pain from limb injury. Emerg Med Australas 2016; 28: 666– 72. 15Taylor DM, Yap CYL, Knott JC, Taylor SE, Phillips GA, Karro J, et al. Midazolam–droperidol, droperidol, or olanzapine for acute agitation: a randomized clinical trial. Ann Emerg Med 2017; 69: 318– 26.e1. 16Chan E, Taylor SE, Marriott J, Barger B. An intervention to encourage ambulance paramedics to bring patient's own medications to the ED: impact on medications brought in and prescribing. Emerg Med Australas 2010; 22: 151– 8. 17Taylor S, Welch S, Harding A, Abbott L, Riyat B, Morrow M, et al. Accuracy of general practitioner medication histories for patients presenting to the emergency department. Aust Fam Physician 2014; 43: 728– 32. 18Kumar N, Knowler C, Strumpman D, Bajorek B. Facilitating medication misadventure risk assessment in the emergency medical unit. J Pharm Pract Res 2011; 41: 108– 12. 19Taylor S, Manias E, Mitri E, Harding A, Taylor D, Weeks A, et al. Emergency department screening tools to assist pharmacists targeting patients at risk for medication related problems [abstract]. Proceedings of Medicines Management; The 44th SHPA National Conference, 2018 Nov 22-25, Brisbane, Australia. 2018. p. 55. Volume49, Issue2April 2019Pages 104-106 ReferencesRelatedInformation
Referência(s)